Capitol Health Ltd announces major acquisition and share purchase plan – here's what you need to know

A low cost acquisition of a radiology imaging centre funded by new shares should be good news for Capitol Health Ltd's (ASX:CAJ) bottom line and its shareholders.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Acquisitions can be a potent way to grow a business, especially when the new purchase adds more than 25% to your bottom line.

That appears to be the case with Capitol Health Ltd's (ASX: CAJ) acquisition of Imaging @ Olympic Park, an MRI centre for sports injuries in Melbourne.

Funded by a share issue – more on that below – the acquisition places an 'Enterprise Value' (cash and debt-free) of $25 million on the imaging business, which earned $10.4m revenue and $3.3 million Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) in 2014.

It will make for a meaningful increase to the $90 million revenue and $7.2 million Net Profit After Tax that Capitol Health earned last year, and is likely to see the company's share price rise to new heights in coming months.

The acquisition is set to be completed in February, and will be funded with a $15 million share placement to eligible investors (those who held shares on or before January 15).

Investors can subscribe for up to $15,000 in shares each, and shares will be valued at a 7.5% discount to the Volume-Weighted Average Price over the five day trading period from 6-12 January 2015.

Based on my rough calculations, this will see shares issued for around $0.76 each.

The total number of shares on issue will rise by roughly 19 million, or 3.8% of the 496 million existing shares.

It's a good deal that delivers mild dilution to shareholders in return for what should be a significant jump in earnings per share.

The new business does look a little expensive at a price of over 8 times the EBITDA figure, but is comparatively cheap compared to Capitol Health's Price to Earnings (P/E) ratio of over 37.

All things considered, if you're thinking about taking up your entitlement, I see a number of positives and no real reason not to.

Motley Fool contributor Sean O'Neill doesn't own shares in any company mentioned.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »